Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy

Pharmacotherapy

Volumn 24, Issue 7 I, 2004, Pages 926-931

  LeBlanc, Michel ^a,b   Bélanger, Chantal ^a,b   Cossette, Pierre ^a,b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Diabetes mellitus; Gatifloxacin; Glyburide; Hypoglycemia; Quinolone

Indexed keywords

ALENDRONIC ACID; ALLOPURINOL; ANTIBIOTIC AGENT; ATORVASTATIN; BICALUTAMIDE; CIPROFLOXACIN; CREATININE; ENOXACIN; FLUTICASONE; GATIFLOXACIN; GLIBENCLAMIDE; GLIPIZIDE; GREPAFLOXACIN; IRBESARTAN; LEVOFLOXACIN; LEVOTHYROXINE; LOMEFLOXACIN; METFORMIN; NORFLOXACIN; ORAL ANTIDIABETIC AGENT; PIPEMIDIC ACID; POTASSIUM CHANNEL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; SULFONYLUREA DERIVATIVE; TEMAFLOXACIN; TOLBUTAMIDE; TOSUFLOXACIN; TROVAFLOXACIN; UNINDEXED DRUG; WARFARIN;

AGED; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GOUT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTHYROIDISM; INFECTION; INSULIN BLOOD LEVEL; INSULIN RELEASE; KIDNEY FUNCTION; LUNG EMBOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PANCREAS ISLET BETA CELL; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PROSTATE CANCER; RAT; RESPIRATORY TRACT INFECTION; SIDE EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; GLYBURIDE; HUMANS; HYPOGLYCEMIA; MALE;

EID: 3042704063     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.9.926.36093     Document Type: Article

References (17)

1. Mandell L, Tillotson G. Safety of fluoroquinolones: an update. Can J Infect Dis 2002;13(1):54-61.
2. Rodvold KA, Piscitelli SC. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety. Clin Infect Dis 1993;17(suppl 1):S192-9.
3. Domagala JM. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994;33:685-706.
4. Bristol-Myers Squibb Canada Inc. Tequin (gatifloxacin) product monograph. Montréal, Quebec, Canada; 2002.
5. Koda-Kimble MA, Carlisle BA. Diabetes mellitus. In: Koda-Kimble MA, Young LY, eds. Applied therapeutics: the clinical use of drugs, 7th ed. Vancouver, BC, Canada: Applied Therapeutics Inc., 2001:48.
6. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med 2003;163:1825-9.
7. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Ann Emerg Med 2000;36(2):160-3.
8. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother 2002;36:1722-6.
9. Parilo MA. Gatifloxacin-associated hypoglycemia. J Pharm Technol 2002;18:319-20.
10. Menzies DJ, Dorsainvil PA, Cunha BA, Johnson DH. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med 2002;113:232-4.
11. Hussein G, Perkins LT, Sternberg M, Bland C. Gatifloxacin-induced hypoglycemia: a case report and review of the literature. Clin Res Regul Aff 2002;19(4):333-9.
12. Maeda N, Tamagawa T, Niki I, et al. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996;117(2):372-6.
13. + channels. Life Sci 2003;73:429-35.
14. Gajjar DA, LaCreta FP, Kollia GD, et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with non-insulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000;20(6 pt 2):76S-86.
15. Health Canada. Canadian adverse reaction newsletter. July 2003;13(3).
16. Japan's Ministry of Health, Labor nd Welfare. Gatiflo dear doctor letter in Japan. March 10, 2003. PJB Publication Ltd.
17. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.